The Burden of Peripheral Artery Disease in China From 1990 to 2019 and Forecasts for 2030: Findings From the Global Burden of Disease Study 2019
ObjectivesThe incidence of peripheral arterial disease (PAD) in China is increasing. We aim to conduct a comprehensive analysis of the burden of PAD.MethodsWe collected information from 1990 to 2019 in the Global Burden of Disease (GBD 2019) study. Joinpoint regression analysis was used to calculate...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-12-01
|
| Series: | International Journal of Public Health |
| Subjects: | |
| Online Access: | https://www.ssph-journal.org/articles/10.3389/ijph.2024.1607352/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850063977662382080 |
|---|---|
| author | Ye Hu Ye Hu Jiyue Gao Jiyue Gao Qiping Zhuo Qiping Zhuo Huixin Liu Meiling Wang Meiling Wang Nina Jiang Nina Jiang Xueqing Wang Xueqing Wang Kainan Wang Kainan Wang Zuowei Zhao Zuowei Zhao Man Li Man Li |
| author_facet | Ye Hu Ye Hu Jiyue Gao Jiyue Gao Qiping Zhuo Qiping Zhuo Huixin Liu Meiling Wang Meiling Wang Nina Jiang Nina Jiang Xueqing Wang Xueqing Wang Kainan Wang Kainan Wang Zuowei Zhao Zuowei Zhao Man Li Man Li |
| author_sort | Ye Hu |
| collection | DOAJ |
| description | ObjectivesThe incidence of peripheral arterial disease (PAD) in China is increasing. We aim to conduct a comprehensive analysis of the burden of PAD.MethodsWe collected information from 1990 to 2019 in the Global Burden of Disease (GBD 2019) study. Joinpoint regression analysis was used to calculate the annual percentage change (APC). Trends in incidence, mortality and DALYs were forecasted by Bayesian age-period-cohort (BAPC) analysis.ResultsIn 2019, the number of new cases and prevalence of PAD in China accounted for nearly a quarter of the global proportion. The age-standardized incidence rate (ASIR) declined after rising until 2005. The age-standardized death rate (ASDR) maintained an upward trend. The DALYs was 0.16 million. Incidence, prevalence and DALYs are predominantly female, except for mortality, which is predominantly male. Smoking predominantly affected males, while hypertension and diabetes had a greater impact on females. By 2030, ASDR is elevated, predominantly in males. ASIR and age-standardized DALY rate decline, predominantly in females.ConclusionIt is urgent for China to develop strategies based on the specific distribution characteristics of the PAD burden. |
| format | Article |
| id | doaj-art-0e7d355eb84e4c7d89e66152f378fd55 |
| institution | DOAJ |
| issn | 1661-8564 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | International Journal of Public Health |
| spelling | doaj-art-0e7d355eb84e4c7d89e66152f378fd552025-08-20T02:49:26ZengFrontiers Media S.A.International Journal of Public Health1661-85642024-12-016910.3389/ijph.2024.16073521607352The Burden of Peripheral Artery Disease in China From 1990 to 2019 and Forecasts for 2030: Findings From the Global Burden of Disease Study 2019Ye Hu0Ye Hu1Jiyue Gao2Jiyue Gao3Qiping Zhuo4Qiping Zhuo5Huixin Liu6Meiling Wang7Meiling Wang8Nina Jiang9Nina Jiang10Xueqing Wang11Xueqing Wang12Kainan Wang13Kainan Wang14Zuowei Zhao15Zuowei Zhao16Man Li17Man Li18Department of Oncology, The Second Hospital of Dalian Medical University, Dalian, Liaoning, ChinaDepartment of Breast Surgery, The Second Hospital of Dalian Medical University, Dalian, Liaoning, ChinaDepartment of Oncology, The Second Hospital of Dalian Medical University, Dalian, Liaoning, ChinaDepartment of Breast Surgery, The Second Hospital of Dalian Medical University, Dalian, Liaoning, ChinaDepartment of Oncology, The Second Hospital of Dalian Medical University, Dalian, Liaoning, ChinaDepartment of Breast Surgery, The Second Hospital of Dalian Medical University, Dalian, Liaoning, ChinaDepartment of Science and Education, Dalian Municipal Central Hospital, Dalian, Liaoning, ChinaDepartment of Oncology, The Second Hospital of Dalian Medical University, Dalian, Liaoning, ChinaDepartment of Breast Surgery, The Second Hospital of Dalian Medical University, Dalian, Liaoning, ChinaDepartment of Oncology, The Second Hospital of Dalian Medical University, Dalian, Liaoning, ChinaDepartment of Breast Surgery, The Second Hospital of Dalian Medical University, Dalian, Liaoning, ChinaDepartment of Oncology, The Second Hospital of Dalian Medical University, Dalian, Liaoning, ChinaDepartment of Breast Surgery, The Second Hospital of Dalian Medical University, Dalian, Liaoning, ChinaDepartment of Oncology, The Second Hospital of Dalian Medical University, Dalian, Liaoning, ChinaDepartment of Breast Surgery, The Second Hospital of Dalian Medical University, Dalian, Liaoning, ChinaDepartment of Oncology, The Second Hospital of Dalian Medical University, Dalian, Liaoning, ChinaDepartment of Breast Surgery, The Second Hospital of Dalian Medical University, Dalian, Liaoning, ChinaDepartment of Oncology, The Second Hospital of Dalian Medical University, Dalian, Liaoning, ChinaDepartment of Breast Surgery, The Second Hospital of Dalian Medical University, Dalian, Liaoning, ChinaObjectivesThe incidence of peripheral arterial disease (PAD) in China is increasing. We aim to conduct a comprehensive analysis of the burden of PAD.MethodsWe collected information from 1990 to 2019 in the Global Burden of Disease (GBD 2019) study. Joinpoint regression analysis was used to calculate the annual percentage change (APC). Trends in incidence, mortality and DALYs were forecasted by Bayesian age-period-cohort (BAPC) analysis.ResultsIn 2019, the number of new cases and prevalence of PAD in China accounted for nearly a quarter of the global proportion. The age-standardized incidence rate (ASIR) declined after rising until 2005. The age-standardized death rate (ASDR) maintained an upward trend. The DALYs was 0.16 million. Incidence, prevalence and DALYs are predominantly female, except for mortality, which is predominantly male. Smoking predominantly affected males, while hypertension and diabetes had a greater impact on females. By 2030, ASDR is elevated, predominantly in males. ASIR and age-standardized DALY rate decline, predominantly in females.ConclusionIt is urgent for China to develop strategies based on the specific distribution characteristics of the PAD burden.https://www.ssph-journal.org/articles/10.3389/ijph.2024.1607352/fulldeath rateincidencedisability-adjusted life yearsChinaperipheral artery disease |
| spellingShingle | Ye Hu Ye Hu Jiyue Gao Jiyue Gao Qiping Zhuo Qiping Zhuo Huixin Liu Meiling Wang Meiling Wang Nina Jiang Nina Jiang Xueqing Wang Xueqing Wang Kainan Wang Kainan Wang Zuowei Zhao Zuowei Zhao Man Li Man Li The Burden of Peripheral Artery Disease in China From 1990 to 2019 and Forecasts for 2030: Findings From the Global Burden of Disease Study 2019 International Journal of Public Health death rate incidence disability-adjusted life years China peripheral artery disease |
| title | The Burden of Peripheral Artery Disease in China From 1990 to 2019 and Forecasts for 2030: Findings From the Global Burden of Disease Study 2019 |
| title_full | The Burden of Peripheral Artery Disease in China From 1990 to 2019 and Forecasts for 2030: Findings From the Global Burden of Disease Study 2019 |
| title_fullStr | The Burden of Peripheral Artery Disease in China From 1990 to 2019 and Forecasts for 2030: Findings From the Global Burden of Disease Study 2019 |
| title_full_unstemmed | The Burden of Peripheral Artery Disease in China From 1990 to 2019 and Forecasts for 2030: Findings From the Global Burden of Disease Study 2019 |
| title_short | The Burden of Peripheral Artery Disease in China From 1990 to 2019 and Forecasts for 2030: Findings From the Global Burden of Disease Study 2019 |
| title_sort | burden of peripheral artery disease in china from 1990 to 2019 and forecasts for 2030 findings from the global burden of disease study 2019 |
| topic | death rate incidence disability-adjusted life years China peripheral artery disease |
| url | https://www.ssph-journal.org/articles/10.3389/ijph.2024.1607352/full |
| work_keys_str_mv | AT yehu theburdenofperipheralarterydiseaseinchinafrom1990to2019andforecastsfor2030findingsfromtheglobalburdenofdiseasestudy2019 AT yehu theburdenofperipheralarterydiseaseinchinafrom1990to2019andforecastsfor2030findingsfromtheglobalburdenofdiseasestudy2019 AT jiyuegao theburdenofperipheralarterydiseaseinchinafrom1990to2019andforecastsfor2030findingsfromtheglobalburdenofdiseasestudy2019 AT jiyuegao theburdenofperipheralarterydiseaseinchinafrom1990to2019andforecastsfor2030findingsfromtheglobalburdenofdiseasestudy2019 AT qipingzhuo theburdenofperipheralarterydiseaseinchinafrom1990to2019andforecastsfor2030findingsfromtheglobalburdenofdiseasestudy2019 AT qipingzhuo theburdenofperipheralarterydiseaseinchinafrom1990to2019andforecastsfor2030findingsfromtheglobalburdenofdiseasestudy2019 AT huixinliu theburdenofperipheralarterydiseaseinchinafrom1990to2019andforecastsfor2030findingsfromtheglobalburdenofdiseasestudy2019 AT meilingwang theburdenofperipheralarterydiseaseinchinafrom1990to2019andforecastsfor2030findingsfromtheglobalburdenofdiseasestudy2019 AT meilingwang theburdenofperipheralarterydiseaseinchinafrom1990to2019andforecastsfor2030findingsfromtheglobalburdenofdiseasestudy2019 AT ninajiang theburdenofperipheralarterydiseaseinchinafrom1990to2019andforecastsfor2030findingsfromtheglobalburdenofdiseasestudy2019 AT ninajiang theburdenofperipheralarterydiseaseinchinafrom1990to2019andforecastsfor2030findingsfromtheglobalburdenofdiseasestudy2019 AT xueqingwang theburdenofperipheralarterydiseaseinchinafrom1990to2019andforecastsfor2030findingsfromtheglobalburdenofdiseasestudy2019 AT xueqingwang theburdenofperipheralarterydiseaseinchinafrom1990to2019andforecastsfor2030findingsfromtheglobalburdenofdiseasestudy2019 AT kainanwang theburdenofperipheralarterydiseaseinchinafrom1990to2019andforecastsfor2030findingsfromtheglobalburdenofdiseasestudy2019 AT kainanwang theburdenofperipheralarterydiseaseinchinafrom1990to2019andforecastsfor2030findingsfromtheglobalburdenofdiseasestudy2019 AT zuoweizhao theburdenofperipheralarterydiseaseinchinafrom1990to2019andforecastsfor2030findingsfromtheglobalburdenofdiseasestudy2019 AT zuoweizhao theburdenofperipheralarterydiseaseinchinafrom1990to2019andforecastsfor2030findingsfromtheglobalburdenofdiseasestudy2019 AT manli theburdenofperipheralarterydiseaseinchinafrom1990to2019andforecastsfor2030findingsfromtheglobalburdenofdiseasestudy2019 AT manli theburdenofperipheralarterydiseaseinchinafrom1990to2019andforecastsfor2030findingsfromtheglobalburdenofdiseasestudy2019 AT yehu burdenofperipheralarterydiseaseinchinafrom1990to2019andforecastsfor2030findingsfromtheglobalburdenofdiseasestudy2019 AT yehu burdenofperipheralarterydiseaseinchinafrom1990to2019andforecastsfor2030findingsfromtheglobalburdenofdiseasestudy2019 AT jiyuegao burdenofperipheralarterydiseaseinchinafrom1990to2019andforecastsfor2030findingsfromtheglobalburdenofdiseasestudy2019 AT jiyuegao burdenofperipheralarterydiseaseinchinafrom1990to2019andforecastsfor2030findingsfromtheglobalburdenofdiseasestudy2019 AT qipingzhuo burdenofperipheralarterydiseaseinchinafrom1990to2019andforecastsfor2030findingsfromtheglobalburdenofdiseasestudy2019 AT qipingzhuo burdenofperipheralarterydiseaseinchinafrom1990to2019andforecastsfor2030findingsfromtheglobalburdenofdiseasestudy2019 AT huixinliu burdenofperipheralarterydiseaseinchinafrom1990to2019andforecastsfor2030findingsfromtheglobalburdenofdiseasestudy2019 AT meilingwang burdenofperipheralarterydiseaseinchinafrom1990to2019andforecastsfor2030findingsfromtheglobalburdenofdiseasestudy2019 AT meilingwang burdenofperipheralarterydiseaseinchinafrom1990to2019andforecastsfor2030findingsfromtheglobalburdenofdiseasestudy2019 AT ninajiang burdenofperipheralarterydiseaseinchinafrom1990to2019andforecastsfor2030findingsfromtheglobalburdenofdiseasestudy2019 AT ninajiang burdenofperipheralarterydiseaseinchinafrom1990to2019andforecastsfor2030findingsfromtheglobalburdenofdiseasestudy2019 AT xueqingwang burdenofperipheralarterydiseaseinchinafrom1990to2019andforecastsfor2030findingsfromtheglobalburdenofdiseasestudy2019 AT xueqingwang burdenofperipheralarterydiseaseinchinafrom1990to2019andforecastsfor2030findingsfromtheglobalburdenofdiseasestudy2019 AT kainanwang burdenofperipheralarterydiseaseinchinafrom1990to2019andforecastsfor2030findingsfromtheglobalburdenofdiseasestudy2019 AT kainanwang burdenofperipheralarterydiseaseinchinafrom1990to2019andforecastsfor2030findingsfromtheglobalburdenofdiseasestudy2019 AT zuoweizhao burdenofperipheralarterydiseaseinchinafrom1990to2019andforecastsfor2030findingsfromtheglobalburdenofdiseasestudy2019 AT zuoweizhao burdenofperipheralarterydiseaseinchinafrom1990to2019andforecastsfor2030findingsfromtheglobalburdenofdiseasestudy2019 AT manli burdenofperipheralarterydiseaseinchinafrom1990to2019andforecastsfor2030findingsfromtheglobalburdenofdiseasestudy2019 AT manli burdenofperipheralarterydiseaseinchinafrom1990to2019andforecastsfor2030findingsfromtheglobalburdenofdiseasestudy2019 |